Conference Coverage

IASLC issues new tobacco declaration


 

AT THE WORLD CONGRESS ON LUNG CANCER

References

These factors have made it difficult for the FDA to address e-cigarettes. “They have done one thing I would have recommended they do: they have proposed deeming authority to take into account a whole variety of [tobacco] products,” he said. Although e-cigarettes contain a nicotine nebulizer with an electronic device, and as such could potentially have been regulated as medical devices just like nicotine patches and gum, courts have instead ruled that they are tobacco products.

“It’s a complex issue, but I’m all for getting people off of cigarettes, and there are alternative nicotine delivery devices,” Dr. Cummings concluded. “I think they need to be shown to be safe and effective.”

Pages

Recommended Reading

ELCC: Survey reveals worldwide underuse of EGFR-mutation testing
MDedge Internal Medicine
AATS: No postpneumonectomy survival benefit in adding radiation to chemotherapy for NSCLC
MDedge Internal Medicine
Nivolumab transforms practice for advanced, refractory nonsquamous NSCLC
MDedge Internal Medicine
ASCO: Precision medicine initiatives take wing
MDedge Internal Medicine
Cigarettes account for slightly under half of smoking-related cancer deaths
MDedge Internal Medicine
Invasive approaches ‘overused’ for evaluating pulmonary nodules
MDedge Internal Medicine
AATS: Metformin linked to better progression-free survival in early-stage NSCLC
MDedge Internal Medicine
Lung cancer biomarker moves into the clinic
MDedge Internal Medicine
Vemurafenib looks promising for several nonmelanoma malignancies
MDedge Internal Medicine
Workshop tackles finer points of lung cancer screening
MDedge Internal Medicine